Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets?

• Author(s): Tone, Luiz Gonzaga
• Date: 2020
• Origin: Oasisbr
• Subject(s): NEOPLASIAS POR TIPO HISTOLÓGICO
• Document Type: Journal article
• Language: English